APA (7th ed.) Citation

M, A., A, Z., S, T., L, C., E, C., AM, M., . . . A, M. (2025). Spotlight on nuclear PD-L1 in ovarian cancer chemoresistance: Hidden but mighty. Frontiers in immunology, 16, 1543529. https://doi.org/10.3389/fimmu.2025.1543529

Chicago Style (17th ed.) Citation

M, Asare-Werehene, Zaker A, Tripathi S, Communal L, Carmona E, Mes-Masson AM, Tsang BK, and Mer A. "Spotlight on Nuclear PD-L1 in Ovarian Cancer Chemoresistance: Hidden but Mighty." Frontiers in Immunology 16 (2025): 1543529. https://doi.org/10.3389/fimmu.2025.1543529.

MLA (9th ed.) Citation

M, Asare-Werehene, et al. "Spotlight on Nuclear PD-L1 in Ovarian Cancer Chemoresistance: Hidden but Mighty." Frontiers in Immunology, vol. 16, 2025, p. 1543529, https://doi.org/10.3389/fimmu.2025.1543529.